Adjuvant vs. salvage radiotherapy for pathologically advanced prostate cancer

Area of Science:

• Oncology
• Radiation Oncology
• Urologic Oncology

Background:

• Radical prostatectomy is a primary treatment for prostate cancer.
• Postoperative radiotherapy is a treatment option for patients with high-risk features.
• The optimal timing of postoperative radiotherapy is a subject of ongoing clinical debate.

Purpose of the Study:

• To evaluate the efficacy and toxicity of postoperative radiotherapy to the prostate bed after radical prostatectomy.
• To discuss the optimal timing of postoperative radiotherapy: adjuvant versus salvage treatment.
• To review current evidence on survival benefits and morbidity associated with postoperative radiotherapy.

Main Methods:

• Review of randomized trials and clinical data on postoperative radiotherapy.
• Analysis of survival outcomes and toxicity profiles.
• Discussion of adjuvant versus salvage radiotherapy strategies.

Main Results:

• Postoperative radiotherapy has demonstrated improved overall survival in a mature randomized trial.
• Randomized trials provide data on the morbidity associated with postoperative radiotherapy.
• High-risk pathological features at radical prostatectomy are associated with improved survival with postoperative radiotherapy.

Conclusions:

• Postoperative radiotherapy improves survival in high-risk prostatectomy patients, with moderate urinary and bowel toxicity.
• The optimal timing of adjuvant versus salvage radiotherapy remains uncertain.
• Further research is needed to clarify the best strategy for postoperative radiotherapy timing.